Medical News

RSS

TIME examines breastfeeding in the Philippines

TIME examines breastfeeding in the Philippines, noting that the country will be one of 18 taking part in a "global moment of breastfeeding" on Friday.

3 Oct 2009

Report highlights rural health care challenges

"Rural residents have even more cause to support a public health insurance plan than those living in cities, advocates of such a plan said Thursday," The Omaha World-Herald reports. "The Center for Rural Affairs in Lyons, Neb., and the Center for Community Change issued a joint report highlighting the particular health care challenges faced by those living in rural parts of the country."

3 Oct 2009

Research study reveals primary chemotherapy benefits

Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, the patients survive on average > 30 months without a recurrence. A study conducted by the Neurooncology Working Group of the German Cancer Society led by researchers from Heidelberg and Z-rich showed that patients in primary therapy benefit to the same extent from chemotherapy alone as from radiation alone.

3 Oct 2009

Mothers must heal physically and psychologically from the first stillbirth before conceiving again

Women who experience a stillbirth in their first pregnancy may be at higher risk for complications or adverse outcomes in their next pregnancy, according to a Kaiser Permanente study that appears online in the October issue of the American Journal of Obstetrics and Gynecology.

3 Oct 2009

Face mask: A vital tool in fighting H1N1

With flu season officially underway on October 4th, Cantel Medical Corp., a company dedicated to infection prevention and control, recommends that Americans take extra precautions against spreading H1N1 influenza. Crosstex International, a subsidiary of Cantel Medical, is one of the largest U.S. manufacturers of face masks.

3 Oct 2009

Healthnostics re-designs its Biomedicine web portal

Healthnostics, Inc., a medical and biotechnology analytics company today delineated its strategy for the biomedical content layer of the re-design of its Biomedicine Web Portal, MedBioWorld.com.

3 Oct 2009

Avexa's ATC Phase III study concludes

Avexa Limited today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results due in the first quarter of 2010.

3 Oct 2009

Study finds link between allergic inflammation and nephropathy in men with type 2 diabetes

For men with type 2 diabetes, a cell type linked to allergic inflammation is closely linked to a key indicator of diabetic kidney disease (nephropathy), suggests a study in the November Clinical Journal of the American Society of Nephrology (CJASN). "Allergy is a common disease that is increasing worldwide, so our findings may have important implications for diabetic nephropathy," comments Michiaki Fukui, MD (Kyoto Prefectural University of Medicine, Japan).

3 Oct 2009

NEDD9 protein stimulates aggressive metastatic breast cancer

Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.

3 Oct 2009

Lawmakers get contributions from industry groups and associated lobbyists

A study by the Center for Responsive Politics and the Sunlight Foundation has found that key lawmakers have received significant contributes not only from major health industry companies - who often lead in contributions to members of Congress - but also from their lobbyists, who have contributed from their personal resources, The Washington Post reports.

3 Oct 2009

Health Enhancement Products, Changing Times Vitamins terminate their current distribution agreement

Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).

3 Oct 2009

New (and old) ideas for health care show possibility of savings, improvements

The search for reform models continues, with news reports exploring the Veterans Administration's "government-run health care," Washington State's "reputation for lower-cost, higher-quality health care," and Kaiser Permanente's new money-saving approach to heart attack treatment.

3 Oct 2009

Interim results of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine clinical trials announced

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults 18 years through 64 years of age and over the age of 65 years.

3 Oct 2009

Researchers screen decades-old frozen infant stool samples to detect norovirus

A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

3 Oct 2009

VA Medical Centers, health care organizations join Planetree to focus on patient-centered health care

As the nation focuses on the future of health care in U.S. hospitals, VA Medical Centers and health care organizations around the country will join Planetree this October to spotlight patient-centered approaches to health care by commemorating the third annual Patient-Centered Care Awareness Month.

3 Oct 2009

Increase in omega-3 fatty acid levels can prevent strokes, according to research

Research led by Hernan A. Bazan, MD, Assistant Professor of Surgery, Section of Vascular Surgery, at LSU Health Sciences Center New Orleans School of Medicine, has found that unstable carotid artery plaques - those in danger of rupturing and leading to a stroke - contain more inflammation and significantly less omega-3 fatty acids than asymptomatic plaques.

3 Oct 2009

Celldex Therapeutics acquires CuraGen Corporation

Celldex Therapeutics, Inc. announced today the successful completion of its acquisition of CuraGen Corporation (Nasdaq: CRGN) pursuant to the previously disclosed Agreement and Plan of Merger, dated as of May 28, 2009, by and among CuraGen, Celldex and Celldex’s merger subsidiary, Cottrell Merger Sub, Inc.

3 Oct 2009

BioDelivery Sciences International files NDS for BEMA Fentanyl

BioDelivery Sciences International, Inc.today announced the filing of a New Drug Submission (NDS) to Health Canada, the regulatory authority in Canada, for BEMA Fentanyl, also known as fentanyl buccal soluble film. BEMA Fentanyl is marketed in the U.S. as ONSOLIS, and the Canadian tradename is to be determined.

3 Oct 2009

Flooding in Atlanta area, a potenital health hazard: Arrow Exterminators

Due to the flooding which hit the metro Atlanta area, Arrow Exterminators, a local pest and termite control company, is reaching out to educate the public on issues related to pest activity that can be expected after a flood and the diseases those pests might carry. As the water recedes, prime conditions and breeding grounds are created.

3 Oct 2009

KYTHERA Biopharmaceuticals presents its two Phase 2 clinical study results

KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today presented detailed results from two double-blind Phase 2 studies, each designed to evaluate the safety and effectiveness of ATX-101, a first-in-class injectable drug for the reduction of small volumes of fat.

3 Oct 2009